SCHEMBL4176478

SCHEMBL4176478

COc1ccc(C=C(C#N)S(=O)(=O)Cc2ccccc2)c(OC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
CYP1A2 P05177 4/20 0.51
CYP3A4 P08684 2/20 0.51
MAPK1 P28482 2/20 0.51
CYP2C9 P11712 1/20 0.51
PTK2B Q14289 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.49
HPGD P15428 2/20 0.49
SLC16A3 O15427 2/20 0.48
SLC16A1 P53985 2/20 0.48
CYP2C19 P33261 1/20 0.48
MAPT P10636 6/20 0.47
NPSR1 Q6W5P4 3/20 0.47
POLB P06746 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ACHE P22303 1/20 0.45
TP53 P04637 1/20 0.45
GAA P10253 1/20 0.45
PAX8 Q06710 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4176474 1.00 ALDH1A1 (0.51) ALDH1A1CYP1A2CYP3A4MAPK1CYP2C9
SCHEMBL4176471 1.00 ALDH1A1 (0.51) ALDH1A1CYP1A2CYP3A4MAPK1CYP2C9
SCHEMBL4185315 0.94 CYP1A2 (0.54) ALDH1A1CYP1A2CYP3A4MAPK1CYP2C9
SCHEMBL4185319 0.94 CYP1A2 (0.54) ALDH1A1CYP1A2CYP3A4MAPK1CYP2C9
SCHEMBL4185323 0.94 CYP1A2 (0.54) ALDH1A1CYP1A2CYP3A4MAPK1CYP2C9
SCHEMBL4168008 0.91 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP3A4MAPK1PTK2B
SCHEMBL4168012 0.91 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP3A4MAPK1PTK2B
SCHEMBL4168014 0.91 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP3A4MAPK1PTK2B
SCHEMBL4182926 0.88 MEN1 (0.46) ALDH1A1CYP1A2CYP3A4MAPK1PTK2B
SCHEMBL4182922 0.88 MEN1 (0.46) ALDH1A1CYP1A2CYP3A4MAPK1PTK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 ALDH1A1 249/4885CYP1A2 1062/4885CYP3A4 2311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.